Research Article

Investigating the quality-of-life scale in patients with placental adhesion disorder undergoing a cesarean hysterectomy and partial uterine resection

Volume: 8 Number: 5 September 4, 2022
EN

Investigating the quality-of-life scale in patients with placental adhesion disorder undergoing a cesarean hysterectomy and partial uterine resection

Abstract

Objectives: This study aimed to investigate the postoperative quality-of-life of patients with placental adhesion disorder undergoing a cesarean hysterectomy and partial uterine resection.

Methods: This was a prospective study performed on 40 patients aged from 25 to 35 years. The subjects were divided into two groups based on whether the uterus was preserved or not following a cesarean hysterectomy and on partial uterine resection. The Turkish version of SF-36 Quality-of-life Scale consisting of 36 items and 8 subscales was applied to the patients.

Results: The participants had a mean age of 31.3  ±  3.2 years. The mean parity, number of cesarean sections and body mass index was 3.45, 3.22 and 29.1  ±  2.9, respectively. The mean physical function score was 83.4  ±  11.61 in the cesarean hysterectomy group and 93.67  ±  8.55 in the partial uterine resection group. A significant difference was found between the cesarean hysterectomy and partial uterine resection groups in terms of their health-related quality-of-life (p  =  0.005).

Conclusions: Patients who underwent partial uterine resection had improved health-related quality-of-life compared to patients who had a cesarean hysterectomy. Choosing uterus-preserving surgery in suitable patients by evaluating the degree of placental adhesion and adhesion size may have a positive effect on the quality-of-life after surgery.

Keywords

References

  1. 1. Srisajjakul S, Prapaisilp P, Bangchokdee S. MRI of placental adhesive disorder. Br J Radiol 2014;87:20140294.
  2. 2. Josephs SC. Obstetric and gynecologic emergencies: a review of indications and interventional techniques. Semin Intervent Radiol 2008;25:337-46.
  3. 3. Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol 2018;219:B2-16.
  4. 4. Cuthbert F, Teixidor Vinas M, Whitby E. The MRI features of placental adhesion disorder-a pictorial review. Br J Radiol 2016;89:20160284.
  5. 5. Dekan S, Linduska N. Normal and pathological placental development: MRI and pathology. In: Prayer D, ed. Fetal MRI. Berlin,Heidelberg: Springer Berlin Heidelberg; 2011:pp. 403-42.
  6. 6. Chantraine F, Blacher S, Berndt S, Palacios-Jaraquemada J, Sarioglu N, Nisolle M, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol 2012;207:188.e1-9.
  7. 7. Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208:219.e1-7.
  8. 8. Knight M; UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007;114:1380-7.

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Publication Date

September 4, 2022

Submission Date

January 23, 2021

Acceptance Date

June 28, 2021

Published in Issue

Year 2022 Volume: 8 Number: 5

AMA
1.Tanrıdan Okçu N, Uysal G, Gürbüz T, Nazik H, Narin R. Investigating the quality-of-life scale in patients with placental adhesion disorder undergoing a cesarean hysterectomy and partial uterine resection. Eur Res J. 2022;8(5):554-559. doi:10.18621/eurj.866522

Cited By